• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

ntebbutt@unimelb.edu.au

Credentials


Position
Clinical (Professor)
Department of Surgery
ORCID

0000-0003-2613-5168

Prof Niall Tebbutt

Clinical (Professor)
Department of Surgery

449 Scholarly works
1 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.
    DOI: 10.1016/j.xcrm.2026.102694
  • 2026

    Journal article

    From chemotherapy to molecular targeted therapy in advanced biliary tract cancer
    DOI: 10.20935/acadonco8171
  • 2026

    Journal article

    Zanidatamab chemotherapy (CT) ± tislelizumab for first-line (1L) HER2-positive (HER2 ) locally advanced, unresectable, or metastatic gastroesophageal adenocarcinoma (mGEA): Primary analysis from HERIZON-GEA-01.
    DOI: 10.1200/jco.2026.44.2_suppl.lba285
  • 2026

    Journal article

    MR-Guided Radiotherapy in Oesophageal Cancer: From Principles to Practice—A Narrative Review
    DOI: 10.3390/curroncol33010034
  • 2025

    Journal article

    Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
    DOI: 10.1038/s41591-025-04030-w
  • 2025

    Journal article

    Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines
    DOI: 10.1038/s42003-025-08251-0
  • 2017

    Research Grant

    Mapping Patterns of Care for People With Pancreatic Cancer: How Close Are We to the Optimal Care Pathway Recommendations?
Niall Tebbutt

RECENT SCHOLARLY WORKS

  • 2025

    Other

    Supplementary Data DS1 from A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
    DOI: 10.1158/1078-0432.30707564
  • 2025

    Journal article

    Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis
    DOI: 10.1016/j.isci.2025.113875
  • 2025

    Journal article

    MRI-Simulator and MR-Linac in Esophageal and Gastric Cancers: An Imaging–Pathology Correlation Study
    DOI: 10.1016/j.ijrobp.2025.06.2963
  • 2025

    Journal article

    1596eTiP A phase I/II study of BDC-4182, a claudin18.2-targeting next generation immune-stimulating antibody conjugate (ISAC), in patients with advanced gastric and gastroesophageal cancer
    DOI: 10.1016/j.annonc.2025.08.2224

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224